Literature DB >> 22362265

Estimating vaccination coverage for the trivalent measles-mumps-rubella vaccine from trivariate serological data.

Nele Goeyvaerts1, Niel Hens, Heidi Theeten, Marc Aerts, Pierre Van Damme, Philippe Beutels.   

Abstract

The effectiveness of childhood immunization programs depends on the vaccination coverage actually achieved. Routinely collected coverage data are not always available, and comparability between countries is often compromised because of different data collection methods. In 2000, Gay developed a method to estimate trivalent vaccination coverage from readily available trivariate serological data on the basis of parametric assumptions related to the rate of seroconversion for each vaccine component and probabilities of natural exposure to infection. Gay's work was indirectly published in a paper by Altmann and Altmann, who derived exact solutions for the parameters on the basis of Gay's modeling equations. In this paper, we propose a general likelihood-based marginal model framework to extend Gay's model by relaxing two of its main assumptions. We use the Bahadur model for trivariate binary data to explicitly account for an association between the disease-specific exposure probabilities. We fit several correlation structures to measles, mumps, and rubella serology from Belgium and Ireland. For both countries, we estimate a small positive pairwise exposure correlation, which improves the fit to the data. However, the effect on the estimated vaccination coverage and its associated variability is fairly moderate. For both Belgium and Ireland, all models reveal that the vaccination coverage achieved during the first 15 years since the introduction of measles, mumps, and rubella immunization is insufficient to eliminate measles.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22362265     DOI: 10.1002/sim.4481

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  2 in total

Review 1.  Use of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings.

Authors:  Natalie G Exum; Nora Pisanic; Douglas A Granger; Kellogg J Schwab; Barbara Detrick; Margaret Kosek; Andrey I Egorov; Shannon M Griffin; Christopher D Heaney
Journal:  Curr Environ Health Rep       Date:  2016-09

2.  Estimating the immunogenicity of measles-rubella vaccination administered during a mass campaign in Lao People's Democratic Republic using multi-valent seroprevalence data.

Authors:  Emilia Vynnycky; Shinsuke Miyano; Katsuhiro Komase; Yoshio Mori; Makoto Takeda; Tomomi Kitamura; Anonh Xeuatvongsa; Masahiko Hachiya
Journal:  Sci Rep       Date:  2019-08-29       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.